| Autor: |
Suurd, Diederik P.D., Visscher, Wouter P., Vorselaars, Wessel M.C.M., van Beek, Dirk-Jan, Spiering, Wilko, Borel Rinkes, Inne H.M., Valk, Gerlof D., Vriens, Menno R., Zarnegar, Rasa, Fahey, Thomas J., Duh, Quan Y., Shen, Wen T., Drake, Frederick T., McAneny, David B., McManus, Catherine, Lee, James A., Grant, Scott B., Grogan, Raymon H., Romero Arenas, Minerva A., Perrier, Nancy D., Sturgeon, Cord, Castelino, Tanya, Mitmaker, Elliot J., Parente, David N., Pasternak, Jesse D., Sidhu, Stan B., Sywak, Mark, D'Amato, Gerardo, Raffaelli, Marco, Schuermans, Valerie, Bouvy, Nicole D., Eker, Hasan H., Bonjer, H. Jaap, Engelsman, Anton F., van Dijkum, Els J.M. Nieveen, Kerstens, Michiel N., Kruijff, Schelto |
| Zdroj: |
Annals of Medicine and Surgery; May 2021, Vol. 65 Issue: 1 |
| Abstrakt: |
Cure of hypertension after adrenalectomy for primary aldosteronism is no certainty and therefore preoperative patient counseling is essential. The Primary Aldosteronism Surgical Outcome (PASO) Score is a useful prediction model with an area under the curve (AUC) of 0.839. The PASO Score includes ‘Target Organ Damage’ (TOD) (i.e., left ventricular hypertrophy and/or microalbuminuria), which is often unavailable during preoperative counseling and might therefore limit its use in clinical practice. We hypothesized that the PASO score would still be useful if TOD is unknown at time of counseling. Therefore, we aimed to examine the predictive performance of the simplified PASO Score, without taking TOD into account. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
